Prostate cancer in Asia:A collaborative report

查看全文 作　　者：Rui [1]Chen;Shancheng [1]Ren;[2]无;Ming Kwong [3]Yiu;Ng Chi [4]Fai;Wai Sam [5]Cheng;Lap Hong [6]Ian;Seiji [7]Naito;Tadashi [8]Matsuda;Elijah [9]Kehinde;Ali [10]Kural;Jason Yichun [11]Chiu;Rainy [12]Umbas;Qiang [13]Wei;Xiaolei [1]Shi;Liqun [14]Zhou;Jian [15]Huang;Yiran [16]Huang;Liping [17]Xie;Lulin [18]Ma;Changjun [19]Yin;Danfeng [20]Xu;Kexin [21]Xu;Zhangqun [22]Ye;Chunxiao [23]Liu;Dingwei [24]Ye;Xin [25]Gao;Qiang [26]Fu;Jianquan [27]Hou;Jianlin [28]Yuan;Dalin [29]He;Tiejun [30]Pan;Qiang [31]Ding;Fengshuo [32]Jin;Benkang [33]Shi;Gongxian [34]Wang;Xiuheng [35]Liu;Dongwen [36]Wang;Zhoujun [37]Shen;Xiangbo [38]Kong;Wanhai [39]Xu;Yaoliang [40]Deng;Haibo [41]Xia;Alexa [42]NCohen;Xu [1]Gao;Chuanliang [1]Xu;Yinghao [1]Sun

机构地区：[1]Department of Urology,Shanghai Changhai Hospital,Second Military Medical University,Shanghai,China;[2]Chinese Prostate Cancer Consortium;[3]Division of Urology,Department of Surgery,University of Hong Kong,Queen Mary Hospital,Hong Kong,China;[4]Division of Urology,Department of Surgery,The Chinese University of Hong Kong,Hong Kong,China;[5]Urology Centre,Singapore General Hospital,Singapore;[6]Department of Urology,Centro Hospitalar Conde de Sao Januario(CHCSJ)Hospital,Macao,China;[7]Department of Urology,Graduate School of Medical Sciences,Kyushu University,Fukuoka,Japan;[8]Department of Urology and Andrology,Hirakata Hospital,Kansai Medical University,Osaka,Japan;[9]Department of Surgery,Kuwait University,Kuwait;[10]Department of Urology,Istanbul Acibadem University,Istanbul,Turkey;[11]Department of Urology,Taipei City Hospital,National Yang-Ming University,Taipei,Taiwan,China;[12]Division of Urology,Department of Surgery,Faculty of Medicine,University of Indonesia,Jakarta,Indonesia;[13]Department of Urology,West China Hospital,Sichuan University,Chengdu,China;[14]Department of Urology,Peking University First Hospital,Institute of Urology,Peking University,National Urological Cancer Center,Beijing,China;[15]Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou,China;[16]Renji Hospital,Shanghai Jiaotong University School of Medicine,Shanghai,China;[17]Department of Urology,First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,China;[18]Department of Urology,Peking University Third Hospital,Beijing,China;[19]State Key Laboratory of Reproductive Medicine,Department of Urology,The First Affiliated Hospital of Nanjing Medical University,Nanjing,China;[20]Department of Urology,Shanghai Changzheng Hospital,Second Military Medical University,Shanghai,China;[21]Peking University People’s Hospital,Beijing,China;[22]Department of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China;[23]Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou,China;[24]Fudan University Shanghai Cancer Center and Department of Oncology,Shanghai,China;[25]Department of Urology,3rd Hospital of Sun Yat-Sen University,Guangzhou,China;[26]Shanghai Jiaotong University Affiliated Sixth People’s Hospital,Shanghai,China;[27]The First Affiliated Hospital of Soochow University,Suzhou,China;[28]Department of Urology,Xijing Hospital,Fourth Military Medical University,Xi’an,China;[29]Department of Urology,First Affiliated Hospital of Medical School,Xi’an Jiaotong University,Xi’an,China;[30]Department of Urology,Wuhan General Hospital of Guangzhou Military Command,Wuhan,China;[31]Department of Urology,Huashan Hospital,Fudan University,Shanghai,China;[32]Department of Urology,Daping Hospital,Chongqing,China;[33]Department of Urology,Qilu Hospital of Shandong University,Jinan,China;[34]Department of Urology,The First Affiliated Hospital of Nanchang University,Nanchang,China;[35]Department of Urology,Renmin Hospital of Wuhan University,Wuhan,China;[36]Department of Urology,First Clinical Medical College,Shanxi Medical University,Taiyuan,China;[37]Department of Urology,Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai,China;[38]Department of Urinary Surgery,China-Japan Union Hospital,Jilin University,Changchun,China;[39]Department of Urology,The Fourth Affiliated Hospital of Harbin Medical University,Harbin,China;[40]The First Affiliated Hospital of Guangxi Medical University,Nanning,China;[41]Department of Urology,Affiliated Hospital of Chifeng College,Chifeng,China;[42]Department of Molecular and Medical Pharmacology,University of California,Los Angeles,CA,USA

出　　处：《Asian Journal of Urology》索引2014年第1卷第1期,共15页

基　　金：supported by the Program for Changjiang Scholars and Innovative Research Team in University scheme of the Ministry of Education of China(NO.IRT1111);the National Basic Research Program of China(2012CB518300);the National Natural Science Foundation of China(81101946);the Shanghai Pujiang Program(12PJD008);Prostate Cancer Foundation Young Investigator Award,Shanghai Municipal Health and Family Planning Commission Outstanding Young Investigator(XYQ2013077). 摘　　要：The incidence of prostate cancer(PCa)within Asian population used to be much lower than in the Western population;however,in recent years the incidence and mortality rate of PCa in some Asian countries have grown rapidly.This collaborative report summarized the latest epidemiology information,risk factors,and racial differences in PCa diagnosis,current status and new trends in surgery management and novel agents for castration-resistant prostate cancer.We believe such information would be helpful in clinical decision making for urologists and oncologists,health-care ministries and medical researchers. 关键词：Prostate cancer Asian population EPIDEMIOLOGY Risk factors Racial differences Surgery management

相关文献

参考文献（75）
引证文献（44）
耦合文献（108）

参考文献(75)

引证文献(44)

耦合文献(108)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Prostate cancer in Asia:A collaborative report

参考文献(75)

引证文献(44)

耦合文献(108)

用户提示